J Diabetes Sci Technol. 2007 Jan;1(1):18-27. doi: 10.1177/193229680700100104.
Immobilization techniques to avoid enzyme loss from oxidase-based biosensors: a one-year study.
Journal of diabetes science and technology
Jody L House, Ellen M Anderson, W Kenneth Ward
PMID: 19888375
PMCID: PMC2769612 DOI: 10.1177/193229680700100104
Abstract
BACKGROUND: Continuous amperometric sensors that measure glucose or lactate require a stable sensitivity, and glutaraldehyde crosslinking has been used widely to avoid enzyme loss. Nonetheless, little data is published on the effectiveness of enzyme immobilization with glutaraldehyde.
METHODS: A combination of electrochemical testing and spectrophotometric assays was used to study the relationship between enzyme shedding and the fabrication procedure. In addition, we studied the relationship between the glutaraldehyde concentration and sensor performance over a period of one year.
RESULTS: The enzyme immobilization process by glutaraldehyde crosslinking to glucose oxidase appears to require at least 24-hours at room temperature to reach completion. In addition, excess free glucose oxidase can be removed by soaking sensors in purified water for 20 minutes. Even with the addition of these steps, however, it appears that there is some free glucose oxidase entrapped within the enzyme layer which contributes to a decline in sensitivity over time. Although it reduces the ultimate sensitivity (probably via a change in the enzyme's natural conformation), glutaraldehyde concentration in the enzyme layer can be increased in order to minimize this instability.
CONCLUSIONS: After exposure of oxidase enzymes to glutaraldehyde, effective crosslinking requires a rinse step and a 24-hour incubation step. In order to minimize the loss of sensor sensitivity over time, the glutaraldehyde concentration can be increased.
Keywords: biosensor; glucose; glucose oxidase; glutaraldehyde; lactate oxidase
References
- Diabetes Technol Ther. 2000 Autumn;2(3):367-76 - PubMed
- Diabetes Technol Ther. 2000 Autumn;2(3):473-7 - PubMed
- Scand J Clin Lab Invest. 1960;12(4):402-7 - PubMed
- Occup Environ Med. 2000 Mar;57(3):165-74 - PubMed
- Biosens Bioelectron. 2002 Oct;17(10):851-7 - PubMed
- Lancet. 1957 Aug 24;273(6991):368-70 - PubMed
- Biomaterials. 1994 Aug;15(10):859-64 - PubMed
- Front Biosci. 2005 Jan 01;10:512-20 - PubMed
- Biosens Bioelectron. 2002 Mar;17(3):181-9 - PubMed
- Diabetes Technol Ther. 2004 Jun;6(3):389-401 - PubMed
- Horm Metab Res. 1994 Nov;26(11):534-7 - PubMed
- Bioconjug Chem. 2005 Nov-Dec;16(6):1451-8 - PubMed
- Anal Biochem. 1997 Nov 15;253(2):162-8 - PubMed
- N Engl J Med. 2001 Nov 8;345(19):1359-67 - PubMed
- Occup Med (Lond). 2003 Mar;53(2):139-42 - PubMed
- J Mol Biol. 1972 Apr 14;65(3):525-9 - PubMed
- J Strength Cond Res. 2002 Feb;16(1):38-43 - PubMed
- Prog Med Chem. 1976;13:271-301 - PubMed
- Clin Chem. 1961 Oct;7:542-5 - PubMed
- Occup Med (Lond). 2000 Jul;50(5):334-6 - PubMed
- J Biotechnol. 2006 Jan 24;121(2):284-9 - PubMed
Publication Types